Carestream Health Continues Advances with 70 Patents Awarded in 2020
Portfolio includes 2D- and 3D-products for general and sub-specialty radiology.
During a year fraught with delays little in-person contact, Carestream Health secured 70 patents in the medical imaging industry, including ones for digital radiography and mobile X-ray systems.
These efforts included both domestic and international patents with 27 being awarded by the U.S. Patent and Trademark Office and 43 coming from European and Asian countries.
According to a company statement, Carestream’s patents include:
- Technology advances with radiology imaging detectors that include processing capabilities that can calibrate and correct X-ray images before transmission
- 3D-image reconstruction methods
- Medical long-length image capture technologies that use a single X-ray exposure for full spinal and extremity imaging
- Mobile X-ray cart technology for bedside imaging with projection radiography, tomosynthesis, and fluoroscopy modes
Overall, Carestream’s product portfolio includes 2D- and 3D-ditigal medical imaging systems that can be implemented in both general and sub-specialty radiology, as well as digital laser imagers that can output medical images to film, a company statement said.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
